These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1405942)

  • 21. A comparison of the clinical efficacy of ranitidine and sucralfate in reflux esophagitis.
    Chopra BK; Kazal HL; Mittal PK; Sibia SS
    J Assoc Physicians India; 1992 Jul; 40(7):439-41. PubMed ID: 1484022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etintidine versus ranitidine in the treatment of reflux esophagitis].
    Wienbeck M; Rohner HG; Hüttemann W; Pelz W
    Dtsch Med Wochenschr; 1986 Sep; 111(39):1501-2. PubMed ID: 3757813
    [No Abstract]   [Full Text] [Related]  

  • 26. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 27. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with ranitidine in reflux esophagitis].
    Balanzoni S; Bagioni P; Turicchia GU; Campagnoni R; Sansone G; Tampieri I
    Minerva Dietol Gastroenterol; 1986; 32(1):35-8. PubMed ID: 3703318
    [No Abstract]   [Full Text] [Related]  

  • 29. A "significant" new drug for erosive esophagitis and gastroesophageal reflux disease.
    Oncology (Williston Park); 1989 Nov; 3(11):116. PubMed ID: 2701405
    [No Abstract]   [Full Text] [Related]  

  • 30. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the clinical efficacy of ranitidine and sucralfate in reflux oesophagitis.
    Chopra BK; Kazal HL; Mittal PK; Sibia SS
    J Assoc Physicians India; 1992 Mar; 40(3):162-3. PubMed ID: 1634480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of ranitidine in the treatment of esophagitis caused by gastro-esophageal acid reflux].
    Nervi M; Conte M; Buttitta F; Spisni R
    Minerva Dietol Gastroenterol; 1989; 35(3):195-9. PubMed ID: 2689913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the cost-effectiveness of medical treatments in acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis.
    Stålhammar NO
    Scand J Gastroenterol Suppl; 1993; 199():8-13. PubMed ID: 8171303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole and reflux oesophagitis.
    Kerr GD
    Aliment Pharmacol Ther; 1994 Apr; 8(2):263. PubMed ID: 8038359
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost and quality effects of treating erosive oesophagitis. A re-evaluation.
    Bloom BS
    Pharmacoeconomics; 1995 Aug; 8(2):139-46. PubMed ID: 10155608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.
    Masci E; Testoni PA; Passaretti S; Guslandi M; Tittobello A
    Drugs Exp Clin Res; 1985; 11(10):687-92. PubMed ID: 3915459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine in the management of gastro-oesophageal reflux disease.
    Nelis GF
    Neth J Med; 1985; 28(5):197-200. PubMed ID: 3892319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.